NCT00192426View on ClinicalTrials.gov

Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.

PHASE3CompletedINTERVENTIONAL
Enrollment

2,400

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

December 31, 2001

Conditions
Influenza
Interventions
BIOLOGICAL

CAIV-T

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

MedImmune LLC

INDUSTRY